Ceramide Suppresses Influenza A Virus Replication In Vitro
Nadia Soudani, Rouba Hage‐Sleiman, Walid G. Karam, Ghassan S. Dbaibo, Hassan Zaraket
Abstract
Nadia Soudani, Rouba Hage‐Sleiman, Walid G. Karam, Ghassan S. Dbaibo, Hassan Zaraket
Abstract
Understanding the effect of sphingolipid metabolism on viral pathogenesis provide important insights into the development of therapeutic strategies against microbial infections. In this study, we demonstrate a critical role of ceramide during influenza A virus infection. We demonstrate that ceramide produced through de novo biosynthesis possess an antiviral role. These observations unlock new opportunities for the development of novel antiviral therapies against influenza.
OpenAlex reports 51 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Understanding the effect of sphingolipid metabolism on viral pathogenesis provide important insights into the development of therapeutic strategies against microbial infections. In this study, we demonstrate a critical role of ceramide during influenza A virus infection. We demonstrate that ceramide produced through de novo biosynthesis possess an antiviral role. These observations unlock new opportunities for the development of novel antiviral therapies against influenza.
Key concepts: Ceramide, Biology, Viral replication, Sphingolipid, Influenza A virus, Ceramide synthase, Virus, Cell biology